BRPI0415639A - formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia - Google Patents
formas de dosagem de oxicodona de liberação controlada, oral, uma vez por diaInfo
- Publication number
- BRPI0415639A BRPI0415639A BRPI0415639-0A BRPI0415639A BRPI0415639A BR PI0415639 A BRPI0415639 A BR PI0415639A BR PI0415639 A BRPI0415639 A BR PI0415639A BR PI0415639 A BRPI0415639 A BR PI0415639A
- Authority
- BR
- Brazil
- Prior art keywords
- profiles
- dosage forms
- controlled release
- oral dosage
- once daily
- Prior art date
Links
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title abstract 2
- 238000013270 controlled release Methods 0.000 title abstract 2
- 229960002085 oxycodone Drugs 0.000 title abstract 2
- 239000006186 oral dosage form Substances 0.000 title 1
- 239000002552 dosage form Substances 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 230000002051 biphasic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51588003P | 2003-10-29 | 2003-10-29 | |
| PCT/US2004/036132 WO2005041968A2 (fr) | 2003-10-29 | 2004-10-28 | Formes posologiques orales d'oxycodone en dose quotidienne unique et a liberation controlee |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0415639A true BRPI0415639A (pt) | 2006-12-12 |
Family
ID=34549453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0415639-0A BRPI0415639A (pt) | 2003-10-29 | 2004-10-28 | formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1677798A2 (fr) |
| JP (1) | JP2007509979A (fr) |
| KR (1) | KR20060108690A (fr) |
| CN (1) | CN1933837A (fr) |
| AU (1) | AU2004285547A1 (fr) |
| BR (1) | BRPI0415639A (fr) |
| CA (1) | CA2546691A1 (fr) |
| EC (1) | ECSP066534A (fr) |
| IL (1) | IL175193A0 (fr) |
| MA (1) | MA28215A1 (fr) |
| NO (1) | NO20062398L (fr) |
| RU (1) | RU2006118323A (fr) |
| WO (1) | WO2005041968A2 (fr) |
| ZA (1) | ZA200604310B (fr) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4806507B2 (ja) | 1999-10-29 | 2011-11-02 | ユーロ−セルティーク エス．エイ． | 制御放出ヒドロコドン処方 |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| CN101653411A (zh) | 2000-10-30 | 2010-02-24 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
| US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE102004032051A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
| US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
| JP5774853B2 (ja) | 2008-01-25 | 2015-09-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 医薬投薬形 |
| US9226907B2 (en) | 2008-02-01 | 2016-01-05 | Abbvie Inc. | Extended release hydrocodone acetaminophen and related methods and uses thereof |
| MX2010012039A (es) | 2008-05-09 | 2010-11-30 | Gruenenthal Gmbh | Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio. |
| BR112012001547A2 (pt) | 2009-07-22 | 2016-03-08 | Gruenenthal Gmbh | forma de dosagem farmacêutica extrusada por fusão a quente |
| ES2428938T3 (es) | 2009-07-22 | 2013-11-12 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación |
| US20110150989A1 (en) * | 2009-12-22 | 2011-06-23 | Mallinkckrodt Inc. | Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
| WO2011124953A2 (fr) * | 2010-04-07 | 2011-10-13 | Lupin Limited | Compositions pharmaceutiques à libération contrôlée de tapentadol |
| CA2808219C (fr) | 2010-09-02 | 2019-05-14 | Gruenenthal Gmbh | Forme pharmaceutique inviolable comportant un sel inorganique |
| CN103179954A (zh) | 2010-09-02 | 2013-06-26 | 格吕伦塔尔有限公司 | 包含阴离子聚合物的抗破碎剂型 |
| PL2736497T3 (pl) | 2011-07-29 | 2018-01-31 | Gruenenthal Gmbh | Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku |
| CA2839123A1 (fr) | 2011-07-29 | 2013-02-07 | Grunenthal Gmbh | Comprime anti-manipulation permettant une liberation immediate de medicament |
| MX356421B (es) | 2012-02-28 | 2018-05-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico. |
| PL2838512T3 (pl) | 2012-04-18 | 2018-12-31 | Grünenthal GmbH | Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| WO2014191396A1 (fr) | 2013-05-29 | 2014-12-04 | Grünenthal GmbH | Forme dosifiée inviolable à profil de libération bimodale |
| MX371432B (es) | 2013-05-29 | 2020-01-30 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido que contiene una o mas particulas. |
| US10624862B2 (en) | 2013-07-12 | 2020-04-21 | Grünenthal GmbH | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| WO2015078891A1 (fr) | 2013-11-26 | 2015-06-04 | Farmaceutici Formenti S.P.A. | Préparation de composition pharmaceutique en poudre par cryo-broyage |
| US20150320690A1 (en) | 2014-05-12 | 2015-11-12 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
| EP3148512A1 (fr) | 2014-05-26 | 2017-04-05 | Grünenthal GmbH | Microparticules protégées contre une libération massive dans l'éthanol |
| BR112017021475A2 (pt) | 2015-04-24 | 2018-07-10 | Gruenenthal Gmbh | forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente |
| AU2016319203A1 (en) | 2015-09-10 | 2018-02-22 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
| KR20250023595A (ko) | 2016-08-10 | 2025-02-18 | 에프. 호프만-라 로슈 아게 | Akt 단백질 키나아제 저해제를 포함하는 약학 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5914131A (en) * | 1994-07-07 | 1999-06-22 | Alza Corporation | Hydromorphone therapy |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| CA2483655A1 (fr) * | 2002-04-29 | 2003-11-13 | Alza Corporation | Procedes et formes dosifiees pour l'administration controlee d'oxycodone |
| MXPA04012021A (es) * | 2002-05-31 | 2005-08-16 | Johnson & Johnson | Formas de dosis y composiciones para la administracion osmotica de dosis variables de oxicodona. |
-
2004
- 2004-10-28 AU AU2004285547A patent/AU2004285547A1/en not_active Abandoned
- 2004-10-28 JP JP2006538357A patent/JP2007509979A/ja not_active Withdrawn
- 2004-10-28 WO PCT/US2004/036132 patent/WO2005041968A2/fr not_active Ceased
- 2004-10-28 EP EP04817492A patent/EP1677798A2/fr not_active Withdrawn
- 2004-10-28 CN CNA2004800394188A patent/CN1933837A/zh active Pending
- 2004-10-28 KR KR1020067010336A patent/KR20060108690A/ko not_active Withdrawn
- 2004-10-28 CA CA002546691A patent/CA2546691A1/fr not_active Abandoned
- 2004-10-28 BR BRPI0415639-0A patent/BRPI0415639A/pt not_active IP Right Cessation
- 2004-10-28 RU RU2006118323/15A patent/RU2006118323A/ru unknown
-
2006
- 2006-04-25 IL IL175193A patent/IL175193A0/en unknown
- 2006-04-28 EC EC2006006534A patent/ECSP066534A/es unknown
- 2006-04-28 MA MA28979A patent/MA28215A1/fr unknown
- 2006-05-26 NO NO20062398A patent/NO20062398L/no not_active Application Discontinuation
- 2006-05-26 ZA ZA200604310A patent/ZA200604310B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200604310B (en) | 2007-11-28 |
| EP1677798A2 (fr) | 2006-07-12 |
| MA28215A1 (fr) | 2006-10-02 |
| AU2004285547A1 (en) | 2005-05-12 |
| JP2007509979A (ja) | 2007-04-19 |
| CN1933837A (zh) | 2007-03-21 |
| ECSP066534A (es) | 2006-11-24 |
| CA2546691A1 (fr) | 2005-05-12 |
| RU2006118323A (ru) | 2007-12-10 |
| KR20060108690A (ko) | 2006-10-18 |
| WO2005041968A2 (fr) | 2005-05-12 |
| IL175193A0 (en) | 2008-04-13 |
| NO20062398L (no) | 2006-07-27 |
| WO2005041968A3 (fr) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0415639A (pt) | formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia | |
| EP1670450B8 (fr) | Compositions pharmaceutiques et procede d'utilisation de la levodopa et de la carbidopa | |
| WO2005041924A3 (fr) | Administration de levodopa et de carbidopa | |
| GEP20125701B (en) | Application of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile | |
| WO2010009892A8 (fr) | Compositions destinées au traitement de la douleur et/ou de l'inflammation | |
| TW200716628A (en) | Novel compounds | |
| GEP20247585B (en) | Furoindazole derivatives | |
| GEP20135927B (en) | 1-benzyl-3-hydroxymethylindaz-ole derivatives and usage thereat treatment of diseases based on mcp-1, cx3cr1 and p40 expression | |
| MX2010002733A (es) | Terapia de intervalo para el tratamiento de tinnitus. | |
| EA200401227A1 (ru) | Система доставки лекарства с контролируемым высвобождением, включающая правастатин | |
| MY135829A (en) | Analeptic and drug combinations | |
| CY1118967T1 (el) | Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης | |
| EA200702522A1 (ru) | Система доставки лекарств в полость рта и способы ее применения | |
| PT1638582E (pt) | Uso de ácido hialurónico para a preparação de composições para o tratamento de aftas recorrentes da cavidade bucal | |
| IS7492A (is) | Lyfjablöndu uppskriftir, sem innifela melantónín | |
| ZA201000581B (en) | 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof | |
| ZA200703441B (en) | Coadministration of tigecycline and digoxin | |
| ATE410152T1 (de) | Therapeutisches system mit amoxicillin und clavulansäure | |
| CL2008002223A1 (es) | Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria. | |
| HRP20090513T1 (hr) | S-mirtazapin, namijenjen liječenju napadaja vrućine | |
| EA200501565A1 (ru) | Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса | |
| TW200626140A (en) | Preventing vertical endoparasite infections | |
| MY140194A (en) | Novel fusidic acid derivatives | |
| SE0203817D0 (sv) | New composition | |
| BRPI0415428A (pt) | formulações terapêuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |